China In-Vitro Diagnostics (IVD) market is likely to grow with double digit CAGR during the period 2018 - 2024. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets.
With an aging population, a rapidly growing middle class and a government encouraging preventive care, China IVD market is slated to show substantial growth in the future. China's quickly aging population means the country is experiencing an explosion of chronic conditions such as diabetes, heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products.
Further, the average Chinese consumer is now willing and able to pay more for healthcare than a decade years ago. Hence, China has the potential for more dramatic growth in the future.
China IVD Market Segment Wise Analysis
Immunoassay captures maximum share of the China IVD market.
Clinical Chemistry holds the 2nd position in China IVD market being followed by Molecular Testing.
The molecular testing market in China is expected to grow in double digits during the forecasted period.
China SMBG market is dominated by foreign IVD companies such as Roche.
Microbiology and Hematology segments are competing closely with each other to grab maximum share of the pie.
China IVD Market Company Analysis
Roche captures maximum share of the China IVD market.
Sysmex Corporation and Mindary Medical are other top two players in the China IVD market.
Sysmex is expanding its business portfolio in China, such as by entering the immunochemistry field there in 2015.
At present, many local players are present in China IVD market and their combined market share was over 47 percent in 2016.
This is the 3rd edition report on China IVD Market. The report titled China IVD Market Size, Share, Trends, Regulations, Reimbursement & Company Analysis - Forecast to 2024 provides a comprehensive analysis of the China IVD Market.
China IVD Market - By Application Segments
1. Clinical Chemistry Market 2. Immunoassay Market 3. Hematology Market 4. Coagulation Market 5. Microbiology Market 6. Molecular Testing Market 7. Self Monitoring of Blood Glucose (SMBG) Market 8. Point of Care Testing (POCT) Market
The group division of Ameritas proudly announces its 17th consecutive certification as a BenchmarkPortal Center of Excellence, solidifying its position as a leader in customer service and support excellence. This prestigious recognition for 2023...
The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to ResearchAndMarkets.com's offering.
Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals....
Driving is the leading cause of work-related death each year in the United States, with nearly 40% of deaths on the job occurring on American roads according to the U.S. Bureau of Labor Statistics. A major contributing factor to road deaths each...
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according...
NastLaw LLC announces: If you purchased certain named generic pharmaceutical drugs directly from certain pharmaceutical manufacturers from May 1, 2009 through December 31, 2019, your rights may be affected by proposed class action settlements.A...
Perspire Sauna Studio, one of the country's largest sauna franchises specializing in full spectrum infrared (IR) and red-light therapy (RLT), is rolling out a new sauna design and member experience through the brand's long-standing partnership with...